The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal evaluation of metabolic dysfunction–associated steatotic liver disease (MASLD)–related biliary tract cancer (BTC) and immunotherapy outcomes.
 
Nakul Shah
No Relationships to Disclose
 
Quentin Kimana
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Felicity Namayanja
No Relationships to Disclose
 
Fen Saj
No Relationships to Disclose
 
Sunyoung Lee
No Relationships to Disclose
 
Zishuo Hu
No Relationships to Disclose
 
Madhulika Eluri
No Relationships to Disclose
 
Lawrence Kwong
Stock and Other Ownership Interests - Sarepta Therapeutics
Research Funding - Array BioPharma
 
Janio Szklaruk
No Relationships to Disclose
 
Milind Javle
Honoraria - AstraZeneca/MedImmune; EMD Serono/Merck; Incyte; Merck; QED Therapeutics; TransThera Biosciences
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; EMD Serono; incyte; Merck; Mundipharma; oncosil; QED Therapeutics
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen